Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	FGFR3 Gene (Entity type)	-0.0070048827
Honokiol Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	0.5381988286972046
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CILP Gene (Entity type)	0.0054331096
US9138393, Climbazole::US9144538, Climbazole Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	0.3887448608875274
Ropinirole Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	0.4183182418346405
oxaprozin Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	0.4449402093887329
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Carbonic anhydrase 2 Protein (Entity type)	Ki
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	ETHE1 Gene (Entity type)	-0.0059648817
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CTBP2 Gene (Entity type)	0.005702654
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	SAT1 Gene (Entity type)	-0.0063002803

Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
FGFR3
Gene (Entity type)
-0.0070048827

Honokiol
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
0.5381988286972046

Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CILP
Gene (Entity type)
0.0054331096

US9138393, Climbazole::US9144538, Climbazole
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
0.3887448608875274

Ropinirole
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
0.4183182418346405

oxaprozin
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
0.4449402093887329

Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Carbonic anhydrase 2
Protein (Entity type)
Ki

Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
ETHE1
Gene (Entity type)
-0.0059648817

Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CTBP2
Gene (Entity type)
0.005702654

Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
SAT1
Gene (Entity type)
-0.0063002803

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.